Clinical trials
Terminated Glioma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
157 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 2 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 5 |
| 2007 | 4 |
| 2008 | 8 |
| 2009 | 7 |
| 2010 | 10 |
| 2011 | 13 |
| 2012 | 10 |
| 2013 | 8 |
| 2014 | 10 |
| 2015 | 8 |
| 2016 | 8 |
| 2017 | 13 |
| 2018 | 7 |
| 2019 | 6 |
| 2020 | 6 |
| 2021 | 11 |
| 2022 | 7 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 157 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 12 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 8 |
| Wake Forest University Health Sciences | 6 |
| Case Comprehensive Cancer Center | 4 |
| Duke University | 4 |
| M.D. Anderson Cancer Center | 4 |
| University of California, San Francisco | 4 |
| Annick Desjardins | 3 |
| Boston Scientific Corporation | 3 |
| H. Lee Moffitt Cancer Center and Research Institute | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioma | 157 |
| Glioblastoma | 78 |
| Brain Neoplasms | 56 |
| Astrocytoma | 54 |
| Oligodendroglioma | 36 |
| Gliosarcoma | 26 |
| Ependymoma | 15 |
| Neoplasms | 12 |
| Central Nervous System Neoplasms | 11 |
| Diffuse Intrinsic Pontine Glioma | 9 |
Trials
Showing 51 to 75 of 157. Each trial links to its page on Pharma Observatory.
57 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.